Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

David Kim

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Hospital Medicine
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    David D. Kim, PhD is an Assistant Professor of Medicine at the University of Chicago. Prior to joining U of Chicago, he was an Assistant Professor and the Program Director of the Cost-Effectiveness Analysis Registry at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center. David is a health economist whose research interest is how to measure and improve the value of health care. Specifically, his research focuses on (1) evaluating distributional health and economic consequences of health policies and medical interventions using simulation modeling, (2) examining variations in the use of low-value services and its downstream consequences, and (3) improving methodology in economic evaluation and research prioritization. David has developed several lifetime disease simulation models for cancer, cardiovascular diseases, diabetes, eye diseases, hepatitis C, and alcohol use disorders. As a lead author of the worked example included in the Second Edition of Cost-Effectiveness in Health and Medicine, he has conducted cost-effectiveness analyses to reflect the comprehensive practice guidelines. Since then, he has written several pieces highlighting the gap between guideline recommendations and actual practice in cost-effectiveness analysis with future directions for improvement. Also, he led a research team to develop a Criteria for Health Economic Quality Evaluation (CHEQUE) tool to create a quality scoring system to assess methodological and reporting criteria. David received his doctorate in Health Economics from the University of Washington and his Master's degree in Biostatistics from the University of Michigan.


    Collapse Biography 
    Collapse education and training
    University of Washington, SeattlePhD08/2016Health Economics
    University of Michigan, Ann ArborMS05/2012Biostatistics
    University of Michigan, Ann Arbor BSE05/2009Biomedical Engineering

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kim DD, Daly AT, Koethe BC, Fendrick AM, Ollendorf DA, Wong JB, Neumann PJ. Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending. JAMA Netw Open. 2022 11 01; 5(11):e2243449. PMID: 36413364.
      View in: PubMed
    2. Do LA, Koethe BC, Daly AT, Chambers JD, Ollendorf DA, Wong JB, Fendrick AM, Neumann PJ, Kim DD. State-Level Variation In Low-Value Care For Commercially Insured And Medicare Advantage Populations. Health Aff (Millwood). 2022 09; 41(9):1281-1290. PMID: 36067429.
      View in: PubMed
    3. Zhu Y, Koethe B, Ollendorf DA, Wong JB, Neumann PJ, Kim DD. Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage Population. Med Care. 2022 12 01; 60(12):888-894. PMID: 36038520.
      View in: PubMed
    4. O'Hearn M, Lauren BN, Wong JB, Kim DD, Mozaffarian D. Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018. J Am Coll Cardiol. 2022 07 12; 80(2):138-151. PMID: 35798448.
      View in: PubMed
    5. Podolsky MI, Present I, Neumann PJ, Kim DD. A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues. Value Health. 2022 08; 25(8):1298-1306. PMID: 35398012.
      View in: PubMed
    6. Ma S, Olchanski N, Cohen JT, Ollendorf DA, Neumann PJ, Kim DD. The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies. Value Health. 2022 08; 25(8):1336-1343. PMID: 35315331.
      View in: PubMed
    7. Silver MC, Neumann PJ, Ma S, Kim DD, Cohen JT, Nyaku M, Roberts C, Sinha A, Ollendorf DA. Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines. Vaccine. 2021 11 05; 39(46):6727-6734. PMID: 34656380.
      View in: PubMed
    8. Kim DD, Basu A. How Does Cost-Effectiveness Analysis Inform Health Care Decisions? AMA J Ethics. 2021 08 01; 23(8):E639-647. PMID: 34459732.
      View in: PubMed
    9. van Dover TJ, Kim DD. Do Centers for Medicare and Medicaid Services Quality Measures Reflect Cost-Effectiveness Evidence? Value Health. 2021 11; 24(11):1586-1591. PMID: 34711358.
      View in: PubMed
    10. Du M, Griecci CF, Cudhea FF, Eom H, Kim DD, Wilde P, Wong JB, Wang YC, Michaud DS, Mozaffarian D, Zhang F. Cost-effectiveness Analysis of Nutrition Facts Added-Sugar Labeling and Obesity-Associated Cancer Rates in the US. JAMA Netw Open. 2021 04 01; 4(4):e217501. PMID: 33904914.
      View in: PubMed
    11. Kim DD, Do LA, Daly AT, Wong JB, Chambers JD, Ollendorf DA, Neumann PJ. An Evidence Review of Low-Value Care Recommendations: Inconsistency and Lack of Economic Evidence Considered. J Gen Intern Med. 2021 11; 36(11):3448-3455. PMID: 33620623.
      View in: PubMed
    12. Hendrix N, Kim DD, Patel KS, Devine B. Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses. Med Decis Making. 2021 04; 41(3):366-372. PMID: 33451278.
      View in: PubMed
    13. Neumann PJ, Cohen JT, Kim DD, Ollendorf DA. Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic. Health Aff (Millwood). 2021 01; 40(1):53-61. PMID: 33211534.
      View in: PubMed
    14. Kim DD, Silver MC, Kunst N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018. Pharmacoeconomics. 2020 10; 38(10):1135-1145. PMID: 32696192.
      View in: PubMed
    15. Kim DD, Ollendorf DA, Neumann PJ, Fendrick AM. Crisis into opportunity: can COVID-19 help set a path to improved health care efficiency? Am J Manag Care. 2020 09; 26(9):369-370. PMID: 32930548.
      View in: PubMed
    16. Du M, Griecci CF, Kim DD, Cudhea F, Ruan M, Eom H, Wong JB, Wilde PE, Michaud DS, Lee Y, Micha R, Mozaffarian D, Zhang FF. Cost-Effectiveness of a National Sugar-Sweetened Beverage Tax to Reduce Cancer Burdens and Disparities in the United States. JNCI Cancer Spectr. 2020 Dec; 4(6):pkaa073. PMID: 33409452.
      View in: PubMed
    17. Ma S, Kim DD, Cohen JT, Neumann PJ. Measuring "Fearonomic Effects" in Valuing Therapies: An Application to COVID-19 in China. Value Health. 2020 11; 23(11):1405-1408. PMID: 33127009.
      View in: PubMed
    18. Panzer AD, Emerson JG, D'Cruz B, Patel A, Dabak S, Isaranuwatchai W, Teerawattananon Y, Ollendorf DA, Neumann PJ, Kim DD. Growth and capacity for cost-effectiveness analysis in Africa. Health Econ. 2020 08; 29(8):945-954. PMID: 32412153.
      View in: PubMed
    19. Feng X, Kim DD, Cohen JT, Neumann PJ, Ollendorf DA. Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter? Int J Technol Assess Health Care. 2020 Apr; 36(2):96-103. PMID: 32340631.
      View in: PubMed
    20. Kim DD, Neumann PJ. Analyzing the Cost Effectiveness of Policy Responses for COVID-19: The Importance of Capturing Social Consequences. Med Decis Making. 2020 04; 40(3):251-253. PMID: 32428432.
      View in: PubMed
    21. Leech AA, Kim DD, Cohen JT, Neumann PJ. Are low and middle-income countries prioritising high-value healthcare interventions? BMJ Glob Health. 2020; 5(2):e001850. PMID: 32133187.
      View in: PubMed
    22. Kim DD, Guzauskas GF, Bennette CS, Basu A, Veenstra DL, Ramsey SD, Carlson JJ. Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment. Pharmacoeconomics. 2020 02; 38(2):171-179. PMID: 31631254.
      View in: PubMed
    23. Isaranuwatchai W, Teerawattananon Y, Archer RA, Luz A, Sharma M, Rattanavipapong W, Anothaisintawee T, Bacon RL, Bhatia T, Bump J, Chalkidou K, Elshaug AG, Kim DD, Reddiar SK, Nakamura R, Neumann PJ, Shichijo A, Smith PC, Culyer AJ. Prevention of non-communicable disease: best buys, wasted buys, and contestable buys. BMJ. 2020 01 28; 368:m141. PMID: 31992592.
      View in: PubMed
    24. Kim DD, Neumann PJ. Comparative Modeling to Inform Health Policy Decisions: A Step Forward. Ann Intern Med. 2019 12 03; 171(11):851-852. PMID: 31683277.
      View in: PubMed
    25. Chambers JD, Panzer AD, Kim DD, Margaretos NM, Neumann PJ. Variation in US private health plans' coverage of orphan drugs. Am J Manag Care. 2019 10; 25(10):508-512. PMID: 31622066.
      View in: PubMed
    26. Kim DD, Wilde PE, Michaud DS, Liu J, Lizewski L, Onopa J, Mozaffarian D, Zhang FF, Wong JB. Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S. Am J Prev Med. 2019 11; 57(5):e143-e152. PMID: 31564600.
      View in: PubMed
    27. Butt T, Liu GG, Kim DD, Neumann PJ. Taking stock of cost-effectiveness analysis of healthcare in China. BMJ Glob Health. 2019; 4(3):e001418. PMID: 31179038.
      View in: PubMed
    28. Emerson J, Panzer A, Cohen JT, Chalkidou K, Teerawattananon Y, Sculpher M, Wilkinson T, Walker D, Neumann PJ, Kim DD. Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS One. 2019; 14(5):e0205633. PMID: 31042714.
      View in: PubMed
    29. Kim DD, Trikalinos TA, Wong JB. Leveraging Cumulative Network Meta-analysis and Value of Information Analysis to Understand the Evolving Value of Medical Research. Med Decis Making. 2019 02; 39(2):119-129. PMID: 30678537.
      View in: PubMed
    30. Kim DD, Cohen JT, Wong JB, Mohit B, Fendrick AM, Kent DM, Neumann PJ. Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency. Health Aff (Millwood). 2019 01; 38(1):60-67. PMID: 30615528.
      View in: PubMed
    31. Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ, Salomon JA, Prosser LA, Owens DK, Meltzer DO, Kuntz KM, Krahn M, Feeny D, Basu A, Russell LB, Siegel JE, Ganiats TG, Sanders GD. Future Directions for Cost-effectiveness Analyses in Health and Medicine. Med Decis Making. 2018 10; 38(7):767-777. PMID: 30248277.
      View in: PubMed
    32. Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD. Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study. Cancer Med. 2018 09; 7(9):4251-4260. PMID: 30030904.
      View in: PubMed
    33. Chambers JD, Kim DD, Pope EF, Graff JS, Wilkinson CL, Neumann PJ. Specialty Drug Coverage Varies Across Commercial Health Plans In The US. Health Aff (Millwood). 2018 07; 37(7):1041-1047. PMID: 29985695.
      View in: PubMed
    34. Kim DD, Arterburn DE, Sullivan SD, Basu A. Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes. Med Care. 2018 07; 56(7):583-588. PMID: 29762271.
      View in: PubMed
    35. Kim DD, Arterburn DE, Sullivan SD, Basu A. Association Between the Publication of Clinical Evidence and the Use of Bariatric Surgery. Obes Surg. 2018 05; 28(5):1321-1328. PMID: 29086183.
      View in: PubMed
    36. Neumann PJ, Anderson JE, Panzer AD, Pope EF, D'Cruz BN, Kim DD, Cohen JT. Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures. Gates Open Res. 2018; 2:5. PMID: 29431169.
      View in: PubMed
    37. Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value Health. 2018 07; 21(7):759-761. PMID: 30005746.
      View in: PubMed
    38. Kim DD, Wilkinson CL, Pope EF, Chambers JD, Cohen JT, Neumann PJ. The influence of time horizon on results of cost-effectiveness analyses. Expert Rev Pharmacoecon Outcomes Res. 2017 Dec; 17(6):615-623. PMID: 28504026.
      View in: PubMed
    39. Kim DD, Basu A. New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on Evaluating Policy Alternatives Rather than Treatment Alternatives. Med Decis Making. 2017 11; 37(8):930-941. PMID: 28441507.
      View in: PubMed
    40. Kim DD, Basu A. Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis. Value Health. 2016 Jul-Aug; 19(5):602-13. PMID: 27565277.
      View in: PubMed
    41. Kim DD, Hutton DW, Raouf AA, Salama M, Hablas A, Seifeldin IA, Soliman AS. Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence. Glob Public Health. 2015; 10(3):296-317. PMID: 25469976.
      View in: PubMed
    42. Stein JD, Newman-Casey PA, Kim DD, Nwanyanwu KH, Johnson MW, Hutton DW. Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema. Ophthalmology. 2013 Sep; 120(9):1835-42. PMID: 23642372.
      View in: PubMed
    43. Stein JD, Kim DD, Peck WW, Giannetti SM, Hutton DW. Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma. Arch Ophthalmol. 2012 Apr; 130(4):497-505. PMID: 22332202.
      View in: PubMed
    Kim's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _